Intellia Therapeutics Inc NTLA
NAS: NTLA | ISIN: US45826J1051 30/04/2025
8,870 USD (+8,17%)
(+8,17%)
30/04/2025
Profiel Intellia Therapeutics Inc
Website: www.intelliatx.com
Hoofdzetel: Cambridge, Massachusetts Verenigde Staten
CEO: John Leonard
Werknemers: 652